Scholar Rock Holding (SRRK) Return on Equity [ROE] (2018 - 2026)
Scholar Rock Holding (SRRK) posted Return on Equity [ROE] of -152.42% for Q2 2026, down 36.79 percentage points from -115.63% a year earlier but up 2.65 percentage points from the prior quarter.
Powered by 
Analysis
Scholar Rock Holding (SRRK) Return on Equity [ROE] (2018 - 2026) Analysis & Trends
For FY2025, Scholar Rock Holding's Return on Equity [ROE] came in at -122.98%, down 40.07 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for five consecutive years, with a five-year change of -76.48 percentage points (FY2020 to FY2025).
- In prior years, Scholar Rock Holding's Return on Equity [ROE] was -82.92% in FY2024 (-14.56 pp), -68.36% in FY2023 (-6.20 pp), -62.16% in FY2022 (-2.13 pp) and -60.03% in FY2021 (-13.53 pp).
- Quarterly Return on Equity [ROE] has run from a low of -214.08% in Q3 2024 to a high of -41.53% in Q3 2022 over five years.
- On a year-over-year basis, Return on Equity [ROE] has declined in each of the last three quarters, with an average year-over-year change of -26.33 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2025, with a gain of 66.40 percentage points; the weakest was Q3 2024, with a drop of 125.64 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -155.07% (Q1 2026), -153.99% (Q4 2025) and -147.68% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Scholar Rock Holding | 5.88 Bn | 5.88 Bn | - | -152.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -152.42% |
| Mar 31, 2026 | -155.07% |
| Dec 31, 2025 | -153.99% |
| Sep 30, 2025 | -147.68% |
| Jun 30, 2025 | -115.63% |
| Mar 31, 2025 | -77.55% |
| Dec 31, 2024 | -109.96% |
| Sep 30, 2024 | -214.08% |
| Jun 30, 2024 | -130.87% |
| Mar 31, 2024 | -91.97% |
| Dec 31, 2023 | -87.20% |
| Sep 30, 2023 | -88.44% |
| Jun 30, 2023 | -76.02% |
| Mar 31, 2023 | -68.71% |
| Dec 31, 2022 | -48.55% |
| Sep 30, 2022 | -41.53% |
| Jun 30, 2022 | -48.93% |
| Mar 31, 2022 | -63.86% |
| Dec 31, 2021 | -72.31% |
| Sep 30, 2021 | -59.75% |
API Access
Scholar Rock Holding Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SRRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "SRRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SRRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();